Open access · US-GOV via ClinicalTrials.gov Clinical trial

Aging White Matter Changes, Executive Dysfunction and Depression

Authors not listed

Weill Medical College of Cornell University · 2002

Dysbiosis Human Randomized controlled trial

Abstract

The purpose of this study is to look at the relationship between age related structural brain changes and changes in depressive symptoms,disability and several aspects of cognitive functioning following treatment with escitalopram.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-15 MST

Cite this

APA

Anonymous. (2002). Aging White Matter Changes, Executive Dysfunction and Depression. <em>Weill Medical College of Cornell University</em>. https://clinicaltrials.gov/study/NCT00918684

Vancouver

Anonymous. Aging White Matter Changes, Executive Dysfunction and Depression. Weill Medical College of Cornell University. 2002.

BibTeX

@misc{anon2002AgingW, title = {Aging White Matter Changes, Executive Dysfunction and Depression}, author = {Anonymous}, journal = {Weill Medical College of Cornell University}, year = {2002}, }